CSI Market
Sign In | Register

Strata Critical Medical Inc (SRTA) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SRTA Annual Cash Flow →
The table below presents a historical view of Strata Critical Medical Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-16.48
Depreciation & amortization11.58
Amortization of Other Assets8.11
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges3.22
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business-0.34
Share-based Compensation8.74
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-1.53
Recapitalization Costs Attributable To Warrant Liabilities-
Increase Decrease In Operating Lease Assets And Liabilities0.07
Excess Of Lease Liability Over Operating Right Of Use Assets-
Fair Value Adjustment Of Other Liabilities-3.44
Increase Decrease In Contract With Customer Liability0.00
Income taxes0.00
Gain (Loss) on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable0.52
Increase (Decrease) in Accounts Payable and Accrued Liabilities-2.65
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.19
Other Working Capital-0.08
Other Noncash Income (Expense)0.00
Other net0.45
Payments for (Proceeds from) Other Operating Activities-1.91
Discontinued operations-0.25
Net Cash flow from Operating Activities9.57
Investing Activities
Capital Expenditures-8.29
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Held-to-maturity Securities30.50
Payments to Acquire Held-to-maturity Securities-6.25
Real Estate Investments0.00
Transaction Costs Paid Related To Sale Of Business Cash Transfer-0.29
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-34.82
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.29
Discontinued operations0.00
Net Cash Flow from Investing Activities-19.15
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.34
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.06
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-4.79
Other net0.00
Proceeds From Exercise Of Common Stock Options-
Proceeds From Recapitalization Of Eic Net Of Issuance Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents31.23
Proceeds From Recapitalization Net Of Issuance Costs-
Deferred Recapitalization Costs-
Restricted Cash And Cash Equivalents0.26
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-5.07
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow1.29
Total Cash Flow-14.65
4 historic quarters locked

Sign in to unlock the full Strata Critical Medical Inc cash flow history.

Sign In Create Free Account

About Strata Critical Medical Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-052256

Figures are derived from filed reports and may be restated. Historical data is subject to revision.